Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Indrayani BiotechBOM:526445 -3.58%54 Days Payable is 59.50 as of Dec. 2025, which is 27% below its 10-year median of 81.00. GuruFocus rates BOM:526445 with a GF Score™ of 54/100 and a GF Value™ of ₹41.09 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 945 Business Services companies, Indrayani Biotech ranks better than 69.31% on this metric.
The historical rank and industry rank for Indrayani Biotech's Days Payable or its related term are showing as below:
BOM:526445'
s Days Payable Range Over the Past 10 Years
Min: 35.2 Med: 81 Max: 134.44
Current: 80.36
During the past 13 years, Indrayani Biotech's highest Days Payable was 134.44. The lowest was 35.20. And the median was 81.00.
BOM:526445's Days Payable is ranked better than 69.31% of 945
companies
in the Business Services industry
Industry Median: 45.81
vs BOM:526445: 80.36
Indrayani Biotech's Days Payable
declined
from Dec. 2024 (282.54) to Dec. 2025 (59.50).
It may suggest that Indrayani Biotechaccelerated paying its suppliers.
Indrayani Biotech Days Payable Related Terms
Indrayani Biotech Days Payable Historical Data
* Premium members only.
The historical data trend for Indrayani Biotech's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:526445 vs CTAS, CPRT, ULS: Days Payable Comparison
For the Specialty Business Services subindustry, Indrayani Biotech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indrayani Biotech Days Payable vs Business Services Industry
For the Business Services industry and Industrials sector, Indrayani Biotech's Days Payable distribution charts can be found below:
* The bar in red indicates where Indrayani Biotech's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Indrayani Biotech's Days Payable for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indrayani Biotech (BOM:526445) has a Days Payable of 59.50 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Indrayani Biotech and its competitors. This is 27% below median its historical median of 81.00. Over the past decade, Indrayani Biotech's Days Payable has ranged from 35.20 to 134.44. According to the industry distribution chart, Indrayani Biotech ranks #290 out of 945 companies in the Business Services industry, placing it in the top 30.7%.
Is Indrayani Biotech's Days Payable too high?
Indrayani Biotech's current Days Payable of 59.50 is 27% below median its 10-year median of 81.00. Over the past 10 years, this metric has ranged from a low of 35.20 to a high of 134.44. The Business Services industry median Days Payable is 45.81. Indrayani Biotech's value of 59.50 is 29.9% above this industry median. Based on the distribution chart, Indrayani Biotech ranks #290 out of 945 companies in the Business Services industry, which is above the industry midpoint. Overall, Indrayani Biotech has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indrayani Biotech's Days Payable compare to CTAS and CPRT?
According to the Business Services industry distribution chart, Indrayani Biotech ranks #290 out of 945 companies for Days Payable. This puts Indrayani Biotech in the upper half of its industry. The industry median Days Payable is 45.81. Indrayani Biotech's value of 59.50 is 29.9% above this benchmark. Historically, Indrayani Biotech's own Days Payable has ranged from 35.20 to 134.44 over the past decade. While the company's 10-year median is 81.00 vs. the industry median of 45.81, Indrayani Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Business Services company?
The median Days Payable among Business Services companies is 45.81, based on 945 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indrayani Biotech's current Days Payable of 59.50 is 29.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Indrayani Biotech and its competitors. For the Business Services industry, the median Days Payable is 45.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indrayani Biotech's current Days Payable is 59.50, which is 27% below median its own 10-year median of 81.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indrayani Biotech stock overvalued right now?
Based on GuruFocus' analysis, Indrayani Biotech (BOM:526445) is currently considered Possible Value Trap. The stock's GF Value™ is ₹41.09, compared to a current price of ₹7.81 — trading 81% below its estimated fair value. The current Days Payable is 59.50, which is 27% below median its 10-year median of 81.00 and 29.9% above the Business Services industry median of 45.81. Indrayani Biotech's overall GF Score™ is 54/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Indrayani Biotech (BOM:526445), the current Days Payable is 59.50 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indrayani Biotech (BOM:526445) Overvalued in 2026?
Based on GuruFocus' analysis, Indrayani Biotech stock appears to be undervalued.
The current stock price of ₹7.81 is trading 81% below its estimated GF Value™ of ₹41.09.
GuruFocus considers Indrayani Biotech to be Possible Value Trap.
Key valuation signals for BOM:526445:
Days Payable: 59.50 (27% below median its 10-year median of 81.00)
GF Value™: ₹41.09 vs. price of ₹7.81 (81% below fair value)
Industry Position: 29.9% above the Business Services median (#290 of 945)
No single metric tells the full story. See the BOM:526445 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indrayani Biotech Ltd operates in the Tri-segment i.e. Foods & Hospitality, Engineering and Healthcare divisions. The company generates its revenue from the sale of food, beverages, and other items; the Sale of Engineering products & Others. The majority of its revenue is generated from the sale of food, beverages, and other items.
54GF Score
Get the complete analysis for BOM:526445
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526445 has been successfully added to your 
